Letter to the Editor| Volume 147, ISSUE 4, P596, April 2010

Obesity and pancreatic cancer: Possible role of the PI3K/Akt pathway

Published:January 18, 2010DOI:
      To the Editors:
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Zyromski N.J.
        • Mathur A.
        • Pitt H.A.
        • Wade T.E.
        • Wang S.
        • Nakshatri P.
        • et al.
        Obesity potentiates the growth and dissemination of pancreatic cancer.
        Surgery. 2009; 146: 258-263
        • Huang X.
        • Chen J.
        Obesity, the PI3 K/Akt signal pathway and colon cancer.
        Obes Rev. 2009; 10: 610-616
        • Chen J.
        Is Src the key to understanding metastasis and developing new treatments for colon cancer?.
        Nat Clin Pract Gastroenterol Hepatol. 2008; 5: 306-307
        • Perugini R.A.
        • McDade T.P.
        • Vittimberga Jr., F.J.
        • Callery M.P.
        Pancreatic cancer cell proliferation is phosphatidylinositol 3-kinase dependent.
        J Surg Res. 2000; 90: 39-44
        • Teranishi F.
        • Takahashi N.
        • Gao N.
        • Akamo Y.
        • Takeyama H.
        • Manabe T.
        • et al.
        Phosphoinositide 3-kinase inhibitor (wortmannin) inhibits pancreatic cancer cell motility and migration induced by hyaluronan in vitro and peritoneal metastasis in vivo.
        Cancer Sci. 2009; 100: 770-777
        • Chen J.
        • Huang X.F.
        Interleukin-6 promotes carcinogenesis through multiple signal pathways. Comment on: Clinical significance of interleukin-6 gene polymorphism and IL-6 serum level in pancreatic adenocarcinoma and chronic pancreatitis.
        Dig Dis Sci. 2009; 54: 1373-1374